Pure ground-glass opacities (GGO) lung adenocarcinoma: surgical resection is curative
Kevin X. Huang,Barry C. Gibney
DOI: https://doi.org/10.21037/jtd-23-1983
2024-06-02
Journal of Thoracic Disease
Abstract:Kevin X. Huang, Barry C. Gibney Department of Surgery, Medical University of South Carolina, Charleston, SC, USA Comment on: Li D, Deng C, Wang S, et al . Ten-Year Follow-up Results of Pure Ground-Glass Opacity-Featured Lung Adenocarcinomas After Surgery. Ann Thorac Surg 2023;116:230-7. Keywords: Lung cancer; pure ground-glass opacity (pure GGO); sublobar resection; lobectomy Submitted Dec 31, 2023. Accepted for publication Apr 17, 2024. Published online May 22, 2024. doi: 10.21037/jtd-23-1983 The promise of low-dose computed tomography (LDCT) scanning and the resulting stage-shift for non-small cell lung cancer (NSCLC) has also presented the challenge of how to manage smaller lesions, especially those that are pure ground glass opacities (GGO) (1,2). It has been previously established that pure GGO lung adenocarcinoma has an excellent 5-year recurrence-free survival (RFS) of 100% after undergoing surgical resection (3,4). However, the indolent nature of pure GGO lung adenocarcinoma necessitates longer term outcomes to properly judge the true overall and recurrence-free survival rates. The recent article by Li et al. (5) "Ten-year follow-up results of pure GGO-featured lung adenocarcinomas after surgery" aims to provide clarity on just this topic. Li and colleagues enrolled 308 patients at a single center in China who underwent surgery during a 6-year period from 2007 to 2013. Using high-resolution computed tomography (CT), the investigators defined GGO as a hazy opacity with the presence of underlying pulmonary vessels or bronchial structures. Additionally, the authors further stratified the lesions as pure GGO—defined as having a consolidation/tumor ratio (CTR) =0, mixed GGO—defined as having a CTR <1, or solid nodule with a CTR equal to 1. The importance of this distinction is demonstrated in significantly worse 5-year RFS for mixed GGO (87.6%) and solid nodules (73.2%) (3). The authors also collected data regarding rates of secondary primary lung cancer (SPLC). 73.4% of their cohort were female, the majority were non-smokers (87%), and the average age was 55.9 (range, 27–76) years. These demographics are important to consider, as the tumor biology may be significantly different in those who are never-smokers (6), and female gender is an independent, favorable, prognostic factor (7). The average tumor diameter was 11.8±5.0 mm on CT and 10.0±4.6 mm on pathology. 60.8% underwent sublobar resection and 39.2% underwent lobectomy. There was no recurrence in any of the patients who underwent sublobar resection or lobectomy 10 years after surgery. In addition, there was no difference in overall survival (OS) or SPLC rates between the two groups. While not the primary focus of their study, Li et al. discuss excellent RFS and OS regardless of pure GGO lung adenocarcinoma or mixed GGO. However, this distinction is particularly important when considering previous studies that have revealed increased incidence of recurrence after resection in patients with mixed GGO lung adenocarcinoma (8-11). Because of this, the authors make the case that pure GGO lung adenocarcinomas should be treated as a distinct entity from mixed GGO lung adenocarcinomas. Given the excellent RFS in the patients undergoing sublobar resection in this population, the authors also advocate for timely resection to prevent the progression of the lesion such that a lobectomy will be required. They further advocate for timely resection to prevent the development of a solid component that will make the lesion a mixed GGO lung adenocarcinoma that no longer has a 100% RFS. The authors also demonstrate a change in the type of operation performed, with 100% of resections being via lobectomy at the beginning of the study, and only around 25% undergoing lobectomy by the end of the study. Since the randomized clinical trial conducted by the Lung Cancer Study Group in 1995 established lobectomy as the standard of care in early-stage lung cancer (12), there have been numerous contemporaneous studies that demonstrate non-inferiority of sublobar resection. Suzuki et al. demonstrated that in GGO-dominant lung cancer (defined as CTR ≤0.25) with maximum tumor diameter ≤2.0 cm sublobar resection achieved a 99.7% 5-year RFS with no incidences of local recurrence (13). Similar results were shown even in the solid nodule population. Altorki et al. enrolled 697 patients with tumor size ≤2.0 cm (excluding patients with pure GGO lesions) in a randomized controlled trial that showed non-inferiority of sublobar resection compared to lobectomy in terms of 5-year disease-free survival (DFS) (63.6% vs. 64.1%) and 5-year OS (80.3% vs. 78.9%) (14). Saji et al. similarly enrolled 1,106 patients with tumor size ≤2.0 cm and CTR >0.5 and demonstrated non-inferiority of sublobar resection compared to lobectomy in terms of 5-year DFS -Abstract Truncated-
respiratory system